Summer Symposium 2015

Heterogeneity in Tumor Progression and Drug Response

Friday, June 12, 2015
9 a.m.-4:30 p.m.
MIT Johnson Athletics Center (Building 34)



  • General registration (including industry/academic professionals, non-MIT students and postdocs, MIT and KI alumni)
  • MIT registration (current MIT faculty, students, postdocs, and staff; MIT email address required

The Koch Institute’s 14th annual Summer Symposium will explore the genetic and epigenetic heterogeneity within tumors that yields diverse cancer phenotypes, such drug resistance. Speakers will highlight the latest breakthroughs in overcoming clinical challenges in cancer diagnostics and therapy. Come join us as we assemble cancer’s complex puzzle.

Confirmed Speakers

Michael Hemann, PhD
Symposium Chair
Associate Professor of Biology
Koch Institute at MIT

Christine A. Iacobuzio-Donahue, MD, PhD
Associate Director for Translational Research, David M. Rubenstein Center for Pancreatic Cancer Research
Memorial Sloan Kettering Cancer Center 

Tyler Jacks, PhD
David H. Koch Professor of Biology
Koch Institute at MIT 

Garry P. Nolan, PhD
Rachford and Carlota Harris Professor, Department of Microbiology & Immunology
Stanford University School of Medicine 

Dana Pe'er, PhD
Associate Professor of Biology and Systems Biology
Columbia University 

Kornelia Polyak, MD, PhD
Professor, Department of Medicine, Harvard Medicial School
Department of Medical Oncology, Dana-Farber Cancer Institute 

Alice Shaw, MD, PhD
Associate Professor, Department of Medicine, Harvard Medical School
Thoracic Cancer Program, Massachusetts General Hospital 

Kimberly Stegmaier, MD
Co-Director, Pediatric Hematologic Maligancy Program, Dana-Farber Cancer Institute & Boston Children's Hospital
Associate Professor of Pediatrics, Harvard Medical School 

Frank Stegmeier, PhD
Novartis Institutes for Biomedical Research

Sir Michael Stratton, PhD
Wellcome Trust Sanger Institute

Charles Swanton, MD, PhD
Francis Crick Institute and UCL Cancer Institute and Hospitals, UK